Evaluation of the ReVive SE Device for Intra-Arterial Thrombectomy in Acute Ischemic Stroke "Re-ACT"


Phase N/A Results N/A

Summary of Purpose

The main objective of this study is to assess the safety and effectiveness of the ReVive SE (Self- Expanding) Neurothrombectomy Device in subjects requiring mechanical thrombectomy when used according to its Instruction for use (IFU).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 August 2017.

1 Jan 2015 13 Jun 2014 31 May 2017 31 May 2017 1 Aug 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



Trial Design

  • Perspective: Prospective
  • Sampling: Non-Probability Sample